Search research articles
Contact Us
Filters
Showing results (241-250 of 255) with videos related to
Page
of 26
Sort By:
JACC. Cardiovascular Interventions
|
July 25, 2020
Role of Post-Stent Physiological Assessment in a Risk Prediction Model After Coronary Stent Implantation
Doyeon Hwang, Joo Myung Lee, Seokhun Yang, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 10, 2020
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Circulation. Cardiovascular Interventions
|
September 8, 2020
Prognostic Impact of Residual Anatomic Disease Burden After Functionally Complete Revascularization
Joo Myung Lee, Doyeon Hwang, Ki Hong Choi, et al.
JACC. Cardiovascular Interventions
|
February 5, 2021
3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation
Xiao-Fei Gao, Zhen Ge, Xiang-Quan Kong, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
January 19, 2019
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes
Michela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
Translational Lung Cancer Research
|
October 24, 2025
Risk of conversion and severe postoperative complications in older patients with non-small cell lung cancer and a history of COVID-19: a population-based study
Hanbo Pan, Ye Dong, Yeqin Guo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
October 24, 2018
The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry
Zhen Ge, Usman Baber, Bimmer E Claessen, et al.
Signal Transduction and Targeted Therapy
|
March 5, 2024
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1
Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, et al.
Cancer Cell
|
April 24, 2026
JYP0322, a highly selective and brain-penetrant ROS1 inhibitor, overcomes ROS1<sup>G2032R</sup> resistance mutation in NSCLC: The first-in-human phase 1 trial
Yuxiang Ma, Jinhui Xue, Fangfang Gao, et al.
Lancet (London, England)
|
September 3, 2024
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials
Marco Valgimigli, Sung-Jin Hong, Felice Gragnano, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 255) with videos related to
Sort By:
Page
of 26
JACC. Cardiovascular Interventions
|
July 25, 2020
Role of Post-Stent Physiological Assessment in a Risk Prediction Model After Coronary Stent Implantation
Doyeon Hwang, Joo Myung Lee, Seokhun Yang, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 10, 2020
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Circulation. Cardiovascular Interventions
|
September 8, 2020
Prognostic Impact of Residual Anatomic Disease Burden After Functionally Complete Revascularization
Joo Myung Lee, Doyeon Hwang, Ki Hong Choi, et al.
JACC. Cardiovascular Interventions
|
February 5, 2021
3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation
Xiao-Fei Gao, Zhen Ge, Xiang-Quan Kong, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
January 19, 2019
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes
Michela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
Translational Lung Cancer Research
|
October 24, 2025
Risk of conversion and severe postoperative complications in older patients with non-small cell lung cancer and a history of COVID-19: a population-based study
Hanbo Pan, Ye Dong, Yeqin Guo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
October 24, 2018
The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry
Zhen Ge, Usman Baber, Bimmer E Claessen, et al.
Signal Transduction and Targeted Therapy
|
March 5, 2024
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1
Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, et al.
Cancer Cell
|
April 24, 2026
JYP0322, a highly selective and brain-penetrant ROS1 inhibitor, overcomes ROS1<sup>G2032R</sup> resistance mutation in NSCLC: The first-in-human phase 1 trial
Yuxiang Ma, Jinhui Xue, Fangfang Gao, et al.
Lancet (London, England)
|
September 3, 2024
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials
Marco Valgimigli, Sung-Jin Hong, Felice Gragnano, et al.
Page
of 26